Clinical trials
Terminated Phase 2 Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Seagen Inc. | 4 |
| Fred Hutchinson Cancer Center | 2 |
| Shionogi | 2 |
| Emory University | 1 |
| Gilead Sciences | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hoffmann-La Roche | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Myelodysplastic Syndromes | 4 |
| Blood Platelet Disorders | 3 |
| Bone Marrow Diseases | 3 |
| Immunoproliferative Disorders | 3 |
| Leukemia | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.